TFE3 and neoplasm: Five neoplasms had different gene fusions including a neoplasm with FUS-CREM gene fusion [6, 9], two SS with SS18- SSX gene fusion, two ASPS with TFE3-ASPSCR1 gene fusion, and one SFT with immunolabeling for STAT6 indicating a STAT6-NAB2 gene fusion (for details, see Table 1).